Idiopathic factor V inhibitor in a patient starting haemodialysis.

Autor: Sutherland, Luke J., Tan, Sarah, Hanna, Merit
Předmět:
Zdroj: Internal Medicine Journal; Feb2023, Vol. 53 Issue 2, p289-292, 4p
Abstrakt: A 74‐year‐old Pacific Island man with end‐stage renal failure planning to start haemodialysis presented with persistent bleeding after tunnelled dialysis catheter insertion. The laboratory findings revealed a prolonged activated partial thromboplastin time of 118 s, prothrombin ratio of 4.2, factor V activity of <2% and a factor V inhibitor of 40 Bethesda Units. No clear underlying aetiology was identified. The bleeding settled with conservative measures and the factor V inhibitor was successfully treated with oral cyclophosphamide for 6 weeks. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index